The Flinn Foundation supports the advancement of the biosciences in Arizona through grantmaking and coordinating Arizona’s Bioscience Roadmap to guide the growth and development of the state’s bioscience sector through 2025. “We are proud to have been recognized by the Flinn Foundation as a contributor to the advancement of bioscience technology in Arizona. This program will help us promote our newest technology which helps researchers develop better drugs and vaccines.” said Dr. Tianwei Jing, President of BI.

BI’s latest technology, Surface Plasmon Resonance Microscopy (SPRM), combines optical microscopy and Surface Plasmon Resonance (SPR) technologies in one instrument. SPRm 200 (#sprm200) is the only scientific solution in the market that enables label-free in vitro measurement of binding reactions and kinetics of individual cells in their native environment and in real time. The instrument offers an easy-to-use solution for investigating drug candidates and cell targets without changing the native environment of the binding sites, thus obtaining more biologically relevant information about the drug candidate. By providing this powerful ability to study molecular interactions directly on the cell, researchers can now expedite drug and vaccine development.

About Biosensing Instrument
Biosensing Instrument Inc (BI), a 2016 R&D Award Winner, supplies innovative and high- performance label-free molecular interaction analysis instruments based on Surface Plasmon Resonance (SPR). BI SPR instruments are used in the life science, drug discovery, antibody characterization, biosensor, and electrochemistry applications to measure the affinity and kinetics of small biomolecules as well as cell membrane, protein-protein, or protein-antibody interactions and biomolecule concentrations.
Additional information about BI can be found at www.biosensingusa.com.